Skin Care Pharma has developed the generic version of Advantan.
The 5 formulations of the original product generate a combined turnover of over €80 million.
|Solution:||DCP procedures in 7 countries finish.|
|Milk:||Half time reached in DCP procedure with 6 countries. Approval is expected in 05.2020|
DCP procedure started in 7 EU countries. Approval is expected in 12.2020
The registration trial was completed positively in 01.2020 and preparations for submission are ongoing. Approval is expected in 01-02.2021
Confirmation of the German authority BfArM concerning the formulation is available
The finest clothing made is a person’s own skin but, of course, society demands something more than this.
— Mark Twain